Under-30s to be offered alternative to AstraZeneca vaccine over blood clot risk

  • by
People under 30 will be offered alternatives to the Oxford/AstraZeneca COVID-19 vaccine as a first choice after a ‘course correction’ by UK health authorities amid concern over a link to rare blood clots.